Literature DB >> 25966934

Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil.

Xinyi Yang1, Keng-Ee Thai2.   

Abstract

Chemotherapy-induced alopecia is a well-established cause of major distress to patients. Permanent chemotherapy-induced alopecia (PCIA) is the absence of or incomplete hair regrowth lasting longer than 6 months after the cessation of chemotherapy and it does not respond to standard treatments of scalp cooling or topical minoxidil. The increasing numbers of reports of PCIA highlight the need for research into an effective treatment. We report a case of a 39 year-old woman with cosmetically significant regrowth after continuous therapy with oral minoxidil.
© 2015 The Australasian College of Dermatologists.

Entities:  

Keywords:  alopecia; chemotherapy-induced alopecia; minoxidil; permanent alopecia; systemic therapy

Year:  2015        PMID: 25966934     DOI: 10.1111/ajd.12350

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  7 in total

1.  What is new in dermatotherapy?

Authors:  Anupam Das; Anand Toshniwal; Bhushan Madke
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

Review 2.  Hair disorders in cancer survivors.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Corina van den Hurk; Shari Goldfarb; Joaquin J Jimenez; Anthony M Rossi; Ralf Paus; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2018-04-14       Impact factor: 11.527

3.  Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study.

Authors:  Eshini Perera; Rodney Sinclair
Journal:  F1000Res       Date:  2017-09-06

4.  Permanent chemotherapy-induced alopecia presenting with erosive pustular dermatosis-like retention hyperkeratosis.

Authors:  Avani Kolla; Lynn Liu; Jeremy Freedman; Nkemjika Ugonabo; Genevieve Kaunitz; Emily Milam; Kristen Lo Sicco; Nooshin K Brinster
Journal:  JAAD Case Rep       Date:  2022-01-06

5.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 6.  Minoxidil and its use in hair disorders: a review.

Authors:  Poonkiat Suchonwanit; Sasima Thammarucha; Kanchana Leerunyakul
Journal:  Drug Des Devel Ther       Date:  2019-08-09       Impact factor: 4.162

7.  Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil.

Authors:  Anna Lyakhovitsky; Oz Segal; Alexander Maly; Abraham Zlotogorski; Aviv Barzilai
Journal:  JAAD Case Rep       Date:  2022-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.